New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
06:23 EDTMDT, JNJ, COVMedtronic deal likely to get 'significant political attention,' says Citigroup
Citigroup believes Medtronic's (MDT) acquisition of Covidien (COV) is likely to get "significant political attention" as the largest agreed upon tax inversion deal. Citi, however, believes both companies have thoroughly vetted the risk. The firm thinks that with annual sales of $27B, the combined company is now "within striking distance" of Johnson & Johnson's (JNJ) MD&D division. Citi has a Buy rating on Medtronic with a $69 price target.
News For MDT;COV;JNJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2015
07:27 EDTJNJJohnson & Johnson drug business likely to remain resilient, says Wells Fargo
Subscribe for More Information
July 29, 2015
12:17 EDTJNJMedivation plummets after Cowen highlights slowing Xtandi trends
Subscribe for More Information
11:23 EDTJNJMedivir says Janssen's Alios BIopharma starts Phase I AL-704 trial
Subscribe for More Information
July 28, 2015
07:05 EDTJNJMacroGenics reports MGD011 advances into clinical development
Subscribe for More Information
July 27, 2015
10:40 EDTJNJLeerink major pharma analyst holds an analyst/industry conference call
Subscribe for More Information
July 23, 2015
17:51 EDTJNJJanssen submits sNDA to update label for Olysio
Subscribe for More Information
July 22, 2015
10:15 EDTJNJ, MDTThoratec downgraded to Market Perform from Outperform at Northland
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use